Other
Efficacy and Safety
0
Pipeline Programs↗
368
Active Trials↗
348
Companies Involved↗
Efficacy and Safety is an early-stage landscape with 0 programs across 348 companies. The most active players are Novartis, AstraZeneca, Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
2,364
clinical trials
Completed1,449 · 61%
Unknown status322 · 14%
Recruiting181 · 8%
Terminated155 · 7%
Not yet recruiting106 · 4%
Active, not recruiting75 · 3%
Other76 · 3%
Clinical Trials
Trial Activity
2364 trials
Efficacy and Safety of Colchicine After PCI
Recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 3·NCT06472908·8,862 enrolled
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Recruiting·—·Phase 2·NCT05968768·24 enrolled
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
Recruiting·IInstitute of Hematology & Blood Diseases Hospital, China·Phase 2·NCT06838949·80 enrolled
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Recruiting·—·N/A·NCT06479291·126 enrolled
Page 1 of 158
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)